From October 22 to 24, 2025, the Global Health Exhibition was grandly held in Riyadh, Saudi Arabia. As the most influential medical event in the Middle East, this exhibition gathered healthcare enterprises and professionals from around the world. Hotgen Biotechnology showcased its comprehensive in vitro diagnostic (IVD) solutions, becoming a major highlight of the event with its outstanding innovation capability and diverse product applications. The company attracted great attention from hospitals, laboratories, and distributors from Saudi Arabia, the UAE, Qatar, and other countries, engaging in in-depth exchanges and discussions.

At the exhibition, Hotgen presented a series of leading products and innovative projects, including MQ60 Mono-Test Chemiluminescence System, integrating the three advantages of direct whole-blood testing, 10-minute results, and single-use packaging, precisely meeting rapid testing needs in primary care and emergency scenarios; C800 Compact Fully Automated Chemiluminescence Immunoassay Analyzer, featuring a compact design and high throughput performance, providing cost-effective and efficient testing solutions for small and medium-sized laboratories; UPT2800 Up-Conversion Phosphor Technology Immunoassay Analyzer, gaining wide attention for its high sensitivity and user-friendly operation experience; TB-IGRA and TB PCR POCT as key demonstration projects, offering precise, rapid, and accessible testing support for TB screening and prevention in the Middle East; Colloidal Gold Rapid Test and ELISA Kits, which further complete the diagnostic system, covering multi-level testing needs from primary screening to laboratory confirmation.
Hotgen is actively promoting its localized manufacturing strategy, joining hands with partners in the Middle East to build an innovative diagnostic ecosystem, contributing to the high-quality development and sustainable improvement of regional healthcare services. Hotgen will continue to take Chinese innovation as its driving force, deepen its presence in the Middle East market, and promote the collaborative development of global healthcare — contributing to a smarter, more efficient, and interconnected future for medical diagnostics.
